Go Ahead And Learn Things Online

Entrepreneurs

Dr. Rick Shinto and Penelope Kokkinides have been working for InnovaCare together, and they have some pretty impressive backgrounds. Rick Shinto has been in the healthcare business for 20 years, and Penelope Kokkinides has 20 years in the field, as well. Together, they are part of a great leadership team.

Rick Shinto’s Career

Rick Shinto has experience in the healthcare industry. He started as a pulmonologist in California. Later, he worked as the vice president at MedPartners, where he worked in medical management. He also worked at Pathways Management, where he was given the task of medical management, again. He’s also been a senior medical officer at Cal Optimal Health Plan. Right now, he’s president of health management at InnovaCare Health. And as you can see, he has an extensive background in healthcare management, as well as experience as a practicing doctor. More recently, Rick Shinto has been awarded the honor of being part of Modern Healthcare’s Top 25 Minority Executives in Healthcare.

Penelope Kokkinides’ Career

Ms. Kokkinides has a long career in the medical field, too. She has 20 years of working with the government health plans, Medicare and Medicaid. At Centerlight HealthCare, she worked as the Chief Management Officer. She’s spent time at Touchstone Health as the head of operations. In June, 2015, she was hired by InnovaCare for the second time, and this time she holds the position of Chief Administrative Officer. With Kokkinides background, she makes an excellent addition to the leadership at InnovaCare Health.

InnovaCare Health

You should also know that InnovaCare Health has a long history of helping people achieve their goals of a health. The company focuses on technology to figure out ways to provide better treatments that are affordable and sustainable. The company also does its best to find solutions with the customer at the heart of decisions.

InnovaCare Health operates through two divisions called Provider Networks and Medicare Advantage Programs. The two largest programs that they offer include PMC Medicare Choice and MMM Healthcare. In 2011, the National Committee for Quality Assurance awarded InnovaCare Health the highest accreditation.

On August 21, 2018, the company announced that a second series of equity lending and venture debt capital had ensued, leaving the medical venture with an additional 42.3 million with which to fund clinical trials, ongoing corporate developments and slated design-to shelf activities.

New, as well as prior contributors, participated in the second round of Renovia’s fundraising efforts, all of whom are in alignment with the medical provider’s vision to make life more bearable for an estimated 250 million who live with urinary incontinence issues, worldwide.

The Longwood Fund, in specific, was a major contributor to the series B funding cycle instituted by the medical company. Another investor in Renovia, OSF Global Services, was one of 6 venture groups that afforded themselves of the opportunity toinvest in the medical venture.

Renovia Co-founder, Marc Beer, was particularly enthused about the latest funding cycle, expressing a belief that new treatment options could be on the horizon for millions of women potentially impacted by Renovia products. One such product, already FDA approved and brought to fruition from research made possible by sponsored monies, is the leva® system kit. Designed to treat women with stress-incontinence and moderate urgency, the product contains a device to provide e-stimulation meant re-train weakened muscles, thereby alleviating leakage.

Other pluses, Beer envisions as coming down the pipeline, include an improved understanding of pelvic-floor dysfunction and a long-term reduction in healthcare costs. These improvements, according to Marc Beer, have the potential to materialize due to an alignment of factors, specifically in the “Combining(of) our innovative and proprietary sensor technologies and form factors with a digital health platform.”

Marc Beer has a quarter-century of experience in the fields of pharmaceuticals, biotechnology and diagnostics. Before becoming the current CEO and chairman of Renovia he worked at Good Start Genetics and Minerva Neuroscience, rising to the level of Chairman in each of the two companies. Learn more: https://renoviainc.com/